Cheng Ya-qi, He Kun, Zheng Xi-xi, Wen Yu-bing, Fan Xiao-hong, Li Ming-xi. Bortezomib plus dexamethasone for a complete remission of heavy chain deposition disease:one case report with a literature review[J]. Journal of Clinical Nephrology, 2022, 22(12): 1047-1050. DOI: 10.3969/j.issn.1671-2390.2022.12.013
Citation:
|
Cheng Ya-qi, He Kun, Zheng Xi-xi, Wen Yu-bing, Fan Xiao-hong, Li Ming-xi. Bortezomib plus dexamethasone for a complete remission of heavy chain deposition disease:one case report with a literature review[J]. Journal of Clinical Nephrology, 2022, 22(12): 1047-1050. DOI: 10.3969/j.issn.1671-2390.2022.12.013
|
Cheng Ya-qi, He Kun, Zheng Xi-xi, Wen Yu-bing, Fan Xiao-hong, Li Ming-xi. Bortezomib plus dexamethasone for a complete remission of heavy chain deposition disease:one case report with a literature review[J]. Journal of Clinical Nephrology, 2022, 22(12): 1047-1050. DOI: 10.3969/j.issn.1671-2390.2022.12.013
Citation:
|
Cheng Ya-qi, He Kun, Zheng Xi-xi, Wen Yu-bing, Fan Xiao-hong, Li Ming-xi. Bortezomib plus dexamethasone for a complete remission of heavy chain deposition disease:one case report with a literature review[J]. Journal of Clinical Nephrology, 2022, 22(12): 1047-1050. DOI: 10.3969/j.issn.1671-2390.2022.12.013
|